Skip to main content
. 2009 Jul 26;10:19. doi: 10.1186/1471-2369-10-19

Table 3.

Treatment characteristics and clinical outcomes of PD-associated peritonitis due to streptococci or other organisms in Australia 2003–2006.

Outcome Streptococcal peritonitis
(n = 287 episodes)
Non-streptococcal peritonitis
(n = 3307 episodes)
P value
Treatment
 Change to 2nd antibiotic regimen 163 (57%) 1847 (56%) 0.8
 Time to 2nd antibiotic regimen 3 [1.75–5] 3 [2–5] 1.0
 Change to 3nd antibiotic regimen 37 (13%) 460 (14%) 0.7
 Time to 3rd antibiotic regimen 7.5 [5–9] 6 [4–10] 0.4
 Total antibiotic treatment duration 13 [8–18] 14 [8–20] 0.10

Hospitalisation
 Number (%) 212 (74%) 2292 (69%) 0.11
 Duration (days) 5 [3–10] 6 [3–12] 0.002

Catheter removal
 Number (%) 29 (10%) 746 (23%) <0.001
 Time to occurrence (days) 7 [3–12] 6 [3–13] 0.8

Temporary haemodialysis
 Number (%) 9 (3%) 143 (4%) 0.3
 Time to occurrence (days) 3 [0.5–8] 6 [3–11.75] 0.08
 Duration (days) 36 [9–89] 68.5 [24.75–104.75] 0.12

Permanent haemodialysis
 Number (%) 25 (9%) 610 (18%) <0.001
 Time to occurrence 8 [5–13] 7 [4–12] 0.4

Death
 Number (%) 4 (1%) 78 (2%) 0.3
 Time to death 7 [3–99.5] 13 [3.25–23.75] 0.7

Results are expressed as number (%) or median days [interquartile range].